Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon

Jorge E. Vidal, Bruce A. McClane, Juliann Saputo, Jaquelyn Parker, Francisco A Uzal

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Clostridium perfringens type B and type C isolates, which produce beta-toxin (CPB), cause fatal diseases originating in the intestines of humans or livestock. Our previous studies demonstrated that CPB is necessary for type C isolate CN3685 to cause bloody necrotic enteritis in a rabbit ileal loop model and also showed that purified CPB, in the presence of trypsin inhibitor (TI), can reproduce type C pathology in rabbit ileal loops. We report here a more complete characterization of the effects of purified CPB in the rabbit small and large intestines. One microgram of purified CPB, in the presence of TI, was found to be sufficient to cause significant accumulation of hemorrhagic luminal fluid in duodenal, jejunal, or ileal loops treated for 6 h with purified CPB, while no damage was observed in corresponding loops receiving CPB (no TI) or TI alone. In contrast to the CPB sensitivity of the small intestine, the colon was not affected by 6 h of treatment with even 90 μg of purified CPB whether or not TI was present. Time course studies showed that purified CPB begins to induce small intestinal damage within 1 h, at which time the duodenum is less damaged than the jejunum or ileum. These observations help to explain why type B and C infections primarily involve the small intestine, establish CPB as a very potent and fast-acting toxin in the small intestines, and confirm a key role for intestinal trypsin as an innate intestinal defense mechanism against CPB-producing C. perfringens isolates.

Original languageEnglish (US)
Pages (from-to)4396-4404
Number of pages9
JournalInfection and Immunity
Volume76
Issue number10
DOIs
StatePublished - Oct 2008

Fingerprint

Trypsin Inhibitors
Small Intestine
Colon
Rabbits
Clostridium perfringens
Enteritis
Large Intestine
Livestock
Jejunum
Ileum
Duodenum
Trypsin
Intestines
Clostridium perfringens CPB protein
Pathology
Infection

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Parasitology
  • Infectious Diseases

Cite this

Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon. / Vidal, Jorge E.; McClane, Bruce A.; Saputo, Juliann; Parker, Jaquelyn; Uzal, Francisco A.

In: Infection and Immunity, Vol. 76, No. 10, 10.2008, p. 4396-4404.

Research output: Contribution to journalArticle

Vidal, Jorge E. ; McClane, Bruce A. ; Saputo, Juliann ; Parker, Jaquelyn ; Uzal, Francisco A. / Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon. In: Infection and Immunity. 2008 ; Vol. 76, No. 10. pp. 4396-4404.
@article{3e8f1001a44b4f068944663b0bd1c488,
title = "Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon",
abstract = "Clostridium perfringens type B and type C isolates, which produce beta-toxin (CPB), cause fatal diseases originating in the intestines of humans or livestock. Our previous studies demonstrated that CPB is necessary for type C isolate CN3685 to cause bloody necrotic enteritis in a rabbit ileal loop model and also showed that purified CPB, in the presence of trypsin inhibitor (TI), can reproduce type C pathology in rabbit ileal loops. We report here a more complete characterization of the effects of purified CPB in the rabbit small and large intestines. One microgram of purified CPB, in the presence of TI, was found to be sufficient to cause significant accumulation of hemorrhagic luminal fluid in duodenal, jejunal, or ileal loops treated for 6 h with purified CPB, while no damage was observed in corresponding loops receiving CPB (no TI) or TI alone. In contrast to the CPB sensitivity of the small intestine, the colon was not affected by 6 h of treatment with even 90 μg of purified CPB whether or not TI was present. Time course studies showed that purified CPB begins to induce small intestinal damage within 1 h, at which time the duodenum is less damaged than the jejunum or ileum. These observations help to explain why type B and C infections primarily involve the small intestine, establish CPB as a very potent and fast-acting toxin in the small intestines, and confirm a key role for intestinal trypsin as an innate intestinal defense mechanism against CPB-producing C. perfringens isolates.",
author = "Vidal, {Jorge E.} and McClane, {Bruce A.} and Juliann Saputo and Jaquelyn Parker and Uzal, {Francisco A}",
year = "2008",
month = "10",
doi = "10.1128/IAI.00547-08",
language = "English (US)",
volume = "76",
pages = "4396--4404",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "10",

}

TY - JOUR

T1 - Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon

AU - Vidal, Jorge E.

AU - McClane, Bruce A.

AU - Saputo, Juliann

AU - Parker, Jaquelyn

AU - Uzal, Francisco A

PY - 2008/10

Y1 - 2008/10

N2 - Clostridium perfringens type B and type C isolates, which produce beta-toxin (CPB), cause fatal diseases originating in the intestines of humans or livestock. Our previous studies demonstrated that CPB is necessary for type C isolate CN3685 to cause bloody necrotic enteritis in a rabbit ileal loop model and also showed that purified CPB, in the presence of trypsin inhibitor (TI), can reproduce type C pathology in rabbit ileal loops. We report here a more complete characterization of the effects of purified CPB in the rabbit small and large intestines. One microgram of purified CPB, in the presence of TI, was found to be sufficient to cause significant accumulation of hemorrhagic luminal fluid in duodenal, jejunal, or ileal loops treated for 6 h with purified CPB, while no damage was observed in corresponding loops receiving CPB (no TI) or TI alone. In contrast to the CPB sensitivity of the small intestine, the colon was not affected by 6 h of treatment with even 90 μg of purified CPB whether or not TI was present. Time course studies showed that purified CPB begins to induce small intestinal damage within 1 h, at which time the duodenum is less damaged than the jejunum or ileum. These observations help to explain why type B and C infections primarily involve the small intestine, establish CPB as a very potent and fast-acting toxin in the small intestines, and confirm a key role for intestinal trypsin as an innate intestinal defense mechanism against CPB-producing C. perfringens isolates.

AB - Clostridium perfringens type B and type C isolates, which produce beta-toxin (CPB), cause fatal diseases originating in the intestines of humans or livestock. Our previous studies demonstrated that CPB is necessary for type C isolate CN3685 to cause bloody necrotic enteritis in a rabbit ileal loop model and also showed that purified CPB, in the presence of trypsin inhibitor (TI), can reproduce type C pathology in rabbit ileal loops. We report here a more complete characterization of the effects of purified CPB in the rabbit small and large intestines. One microgram of purified CPB, in the presence of TI, was found to be sufficient to cause significant accumulation of hemorrhagic luminal fluid in duodenal, jejunal, or ileal loops treated for 6 h with purified CPB, while no damage was observed in corresponding loops receiving CPB (no TI) or TI alone. In contrast to the CPB sensitivity of the small intestine, the colon was not affected by 6 h of treatment with even 90 μg of purified CPB whether or not TI was present. Time course studies showed that purified CPB begins to induce small intestinal damage within 1 h, at which time the duodenum is less damaged than the jejunum or ileum. These observations help to explain why type B and C infections primarily involve the small intestine, establish CPB as a very potent and fast-acting toxin in the small intestines, and confirm a key role for intestinal trypsin as an innate intestinal defense mechanism against CPB-producing C. perfringens isolates.

UR - http://www.scopus.com/inward/record.url?scp=53649107447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53649107447&partnerID=8YFLogxK

U2 - 10.1128/IAI.00547-08

DO - 10.1128/IAI.00547-08

M3 - Article

C2 - 18625730

AN - SCOPUS:53649107447

VL - 76

SP - 4396

EP - 4404

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 10

ER -